|
WO1983001451A1
(en)
|
1981-10-23 |
1983-04-28 |
Molecular Biosystems Inc |
Oligonucleotide therapeutic agent and methods of making same
|
|
US4541087A
(en)
*
|
1983-06-27 |
1985-09-10 |
Confertech International, Inc. |
Digital teleconferencing control device, system and method
|
|
CA1339596C
(en)
|
1987-08-07 |
1997-12-23 |
New England Medical Center Hospitals, Inc. |
Viral expression inhibitors
|
|
US4958013A
(en)
*
|
1989-06-06 |
1990-09-18 |
Northwestern University |
Cholesteryl modified oligonucleotides
|
|
US5399676A
(en)
|
1989-10-23 |
1995-03-21 |
Gilead Sciences |
Oligonucleotides with inverted polarity
|
|
EP0468520A3
(en)
|
1990-07-27 |
1992-07-01 |
Mitsui Toatsu Chemicals, Inc. |
Immunostimulatory remedies containing palindromic dna sequences
|
|
CA2140542A1
(en)
|
1992-07-27 |
1994-02-03 |
Abeysingle Padmapriya |
Oligonucleotide alkylphosphonothioates
|
|
US5558988A
(en)
*
|
1992-11-13 |
1996-09-24 |
Thomas Jefferson University |
Primers and methods for detecting mutations in the procollagen II gene that indicate a genetic predisposition for osteoarthritis
|
|
US6605708B1
(en)
|
1993-07-28 |
2003-08-12 |
Hybridon, Inc. |
Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom
|
|
DE4338704A1
(de)
|
1993-11-12 |
1995-05-18 |
Hoechst Ag |
Stabilisierte Oligonucleotide und deren Verwendung
|
|
US5646126A
(en)
|
1994-02-28 |
1997-07-08 |
Epoch Pharmaceuticals |
Sterol modified oligonucleotide duplexes having anticancer activity
|
|
US5596091A
(en)
|
1994-03-18 |
1997-01-21 |
The Regents Of The University Of California |
Antisense oligonucleotides comprising 5-aminoalkyl pyrimidine nucleotides
|
|
WO1995026204A1
(en)
|
1994-03-25 |
1995-10-05 |
Isis Pharmaceuticals, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US6727230B1
(en)
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US20030050263A1
(en)
|
1994-07-15 |
2003-03-13 |
The University Of Iowa Research Foundation |
Methods and products for treating HIV infection
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US20030026782A1
(en)
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
|
ATE509102T1
(de)
|
1994-07-15 |
2011-05-15 |
Univ Iowa Res Found |
Immunomodulatorische oligonukleotide
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
DE19502912A1
(de)
*
|
1995-01-31 |
1996-08-01 |
Hoechst Ag |
G-Cap Stabilisierte Oligonucleotide
|
|
US5968909A
(en)
|
1995-08-04 |
1999-10-19 |
Hybridon, Inc. |
Method of modulating gene expression with reduced immunostimulatory response
|
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
|
US7432048B2
(en)
*
|
1996-11-29 |
2008-10-07 |
Third Wave Technologies, Inc. |
Reactions on a solid surface
|
|
US6030955A
(en)
*
|
1996-03-21 |
2000-02-29 |
The Trustees Of Columbia University In The City Of New York And Imclone Systems, Inc. |
Methods of affecting intracellular phosphorylation of tyrosine using phosphorothioate oligonucleotides, and antiangiogenic and antiproliferative uses thereof
|
|
US5856462A
(en)
|
1996-09-10 |
1999-01-05 |
Hybridon Incorporated |
Oligonucleotides having modified CpG dinucleosides
|
|
ES2241042T3
(es)
|
1996-10-11 |
2005-10-16 |
The Regents Of The University Of California |
Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora.
|
|
EP0855184A1
(en)
*
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
WO1998037919A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6426334B1
(en)
|
1997-04-30 |
2002-07-30 |
Hybridon, Inc. |
Oligonucleotide mediated specific cytokine induction and reduction of tumor growth in a mammal
|
|
US6835395B1
(en)
|
1997-05-14 |
2004-12-28 |
The University Of British Columbia |
Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
|
|
AU7690898A
(en)
|
1997-05-20 |
1998-12-11 |
Ottawa Civic Hospital Loeb Research Institute |
Vectors and methods for immunization or therapeutic protocols
|
|
WO1998055495A2
(en)
|
1997-06-06 |
1998-12-10 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
US6589940B1
(en)
|
1997-06-06 |
2003-07-08 |
Dynavax Technologies Corporation |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
US20040006034A1
(en)
|
1998-06-05 |
2004-01-08 |
Eyal Raz |
Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
|
|
US6221882B1
(en)
|
1997-07-03 |
2001-04-24 |
University Of Iowa Research Foundation |
Methods for inhibiting immunostimulatory DNA associated responses
|
|
DE19750702A1
(de)
*
|
1997-11-15 |
1999-05-27 |
Hoechst Marion Roussel De Gmbh |
Antisense Oligonucleotide gegen Tenascin zur Behandlung von Vitiligo
|
|
US7393630B2
(en)
*
|
1997-12-16 |
2008-07-01 |
Novartis Vaccines And Diagnostics, Inc. |
Use of microparticles combined with submicron oil-in-water emulsions
|
|
ATE356630T1
(de)
|
1998-04-03 |
2007-04-15 |
Univ Iowa Res Found |
Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
|
|
EP1595946A3
(en)
*
|
1998-04-14 |
2006-01-11 |
Sugen, Inc. |
STE20-related protein kinases
|
|
DE69926742T2
(de)
*
|
1998-04-14 |
2006-06-14 |
Sugen Inc |
Ste20-verwandte proteinkinasen
|
|
EP1077708A1
(en)
|
1998-05-06 |
2001-02-28 |
University Of Iowa Research Foundation |
Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
|
|
ATE305507T1
(de)
|
1998-05-14 |
2005-10-15 |
Coley Pharm Gmbh |
Verfahren zur regulierung der hematopoiese mit hilfe von cpg oligonukleotide
|
|
PT1077722E
(pt)
|
1998-05-22 |
2006-12-29 |
Coley Pharm Group Inc |
Produtos e composições para utilização na indução da imunidade mucosal
|
|
US6562798B1
(en)
*
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
JP2002521489A
(ja)
|
1998-07-27 |
2002-07-16 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
ＣｐＧオリゴヌクレオチドの立体異性体および関連する方法
|
|
JP2002523048A
(ja)
*
|
1998-08-20 |
2002-07-30 |
イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー |
共役二重結合の形成に関係する植物脂肪酸改質酵素の遺伝子
|
|
FR2783170B1
(fr)
|
1998-09-11 |
2004-07-16 |
Pasteur Merieux Serums Vacc |
Emulsion immunostimulante
|
|
AU1915500A
(en)
*
|
1998-11-20 |
2000-06-13 |
Bristol-Myers Squibb Company |
Water soluble prodrugs of azole compounds
|
|
US6207819B1
(en)
|
1999-02-12 |
2001-03-27 |
Isis Pharmaceuticals, Inc. |
Compounds, processes and intermediates for synthesis of mixed backbone oligomeric compounds
|
|
WO2000054803A2
(en)
|
1999-03-16 |
2000-09-21 |
Panacea Pharmaceuticals, Llc |
Immunostimulatory nucleic acids and antigens
|
|
AU4343700A
(en)
*
|
1999-04-12 |
2000-11-14 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US6977245B2
(en)
*
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
US6479504B1
(en)
|
1999-06-16 |
2002-11-12 |
The University Of Iowa Research Foundation |
Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases
|
|
US6514948B1
(en)
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
|
DE19935756A1
(de)
|
1999-07-27 |
2001-02-08 |
Mologen Forschungs Entwicklung |
Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
|
|
DE19935302A1
(de)
*
|
1999-07-28 |
2001-02-08 |
Aventis Pharma Gmbh |
Konjugate und Verfahren zu deren Herstellung sowie deren Verwendung zum Transport von Molekülen über biologische Membranen
|
|
US6822086B1
(en)
*
|
1999-08-09 |
2004-11-23 |
The General Hospital Corporation |
Drug-carrier complexes and methods of use thereof
|
|
DK1200580T3
(da)
|
1999-08-13 |
2005-04-11 |
Hybridon Inc |
Modulering af oligonukleotid-CpG-medieret immunstimulering ved positionel modifikation
|
|
SK287400B6
(sk)
|
1999-09-25 |
2010-08-09 |
University Of Iowa Research Foundation |
Prostriedok s obsahom imunostimulačnej nukleovej kyseliny a jeho použitie na stimuláciu imunitnej reakcie
|
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
EP1322655B1
(en)
*
|
2000-01-14 |
2007-11-14 |
The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
|
EP1311288A1
(en)
|
2000-01-20 |
2003-05-21 |
Ottawa Health Research Institute |
Immunostimulatory nucleic acids for inducing a th2 immune response
|
|
DE60132170T2
(de)
|
2000-01-26 |
2008-12-18 |
Idera Pharmaceuticals, Inc., Cambridge |
MODULIERUNG DER DURCH CpG-OLIGONUKLEOTIDE VERURSACHTEN IMMUNSTIMULIERUNG DURCH POSITIONSBEDINGTE VERÄNDERUNG VON NUKLEOSIDEN
|
|
US7585847B2
(en)
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
US20020156033A1
(en)
|
2000-03-03 |
2002-10-24 |
Bratzler Robert L. |
Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer
|
|
US20040131628A1
(en)
|
2000-03-08 |
2004-07-08 |
Bratzler Robert L. |
Nucleic acids for the treatment of disorders associated with microorganisms
|
|
JP3585420B2
(ja)
*
|
2000-04-20 |
2004-11-04 |
株式会社椿本チエイン |
チェーン用巻き加工品及びその製造方法
|
|
AU2001259706A1
(en)
|
2000-05-09 |
2001-11-20 |
Reliable Biopharmaceutical, Inc. |
Polymeric compounds useful as prodrugs
|
|
US6339630B1
(en)
*
|
2000-05-18 |
2002-01-15 |
The United States Of America As Represented By The United States Department Of Energy |
Sealed drive screw operator
|
|
AU2001270134B2
(en)
|
2000-06-22 |
2006-06-15 |
University Of Iowa Research Foundation |
Methods for enhancing antibody-induced cell lysis and treating cancer
|
|
US20020165178A1
(en)
|
2000-06-28 |
2002-11-07 |
Christian Schetter |
Immunostimulatory nucleic acids for the treatment of anemia, thrombocytopenia, and neutropenia
|
|
US20020198165A1
(en)
|
2000-08-01 |
2002-12-26 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of gastric ulcers
|
|
US20020091097A1
(en)
|
2000-09-07 |
2002-07-11 |
Bratzler Robert L. |
Nucleic acids for the prevention and treatment of sexually transmitted diseases
|
|
JP2005500806A
(ja)
|
2000-09-15 |
2005-01-13 |
コーリー ファーマシューティカル ゲーエムベーハー |
ＣｐＧに基づく免疫アゴニスト／免疫アンタゴニストの高スループットスクリーニングのためのプロセス
|
|
AU9475001A
(en)
*
|
2000-09-26 |
2002-04-08 |
Hybridon Inc |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
|
FR2814958B1
(fr)
|
2000-10-06 |
2003-03-07 |
Aventis Pasteur |
Composition vaccinale
|
|
GB0025577D0
(en)
|
2000-10-18 |
2000-12-06 |
Smithkline Beecham Biolog |
Vaccine
|
|
ATE398175T1
(de)
|
2000-12-08 |
2008-07-15 |
Coley Pharmaceuticals Gmbh |
Cpg-artige nukleinsäuren und verfahren zu ihrer verwendung
|
|
WO2002053141A2
(en)
|
2000-12-14 |
2002-07-11 |
Coley Pharmaceutical Group, Inc. |
Inhibition of angiogenesis by nucleic acids
|
|
US20030050268A1
(en)
|
2001-03-29 |
2003-03-13 |
Krieg Arthur M. |
Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
|
|
US20030052063A1
(en)
*
|
2001-03-30 |
2003-03-20 |
Motoaki Sakashita |
Decontamination method and apparatus
|
|
US7713942B2
(en)
|
2001-04-04 |
2010-05-11 |
Nordic Vaccine Technology A/S |
Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides
|
|
US7105495B2
(en)
|
2001-04-30 |
2006-09-12 |
Idera Pharmaceuticals, Inc. |
Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
|
|
CA2451974C
(en)
|
2001-06-21 |
2014-10-14 |
Karen L. Fearon |
Chimeric immunomodulatory compounds and methods of using the same
|
|
US7785610B2
(en)
*
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
|
US20040132677A1
(en)
|
2001-06-21 |
2004-07-08 |
Fearon Karen L. |
Chimeric immunomodulatory compounds and methods of using the same-IV
|
|
US6893572B2
(en)
*
|
2001-07-12 |
2005-05-17 |
Western Environmental Engineering Company |
Solids accumulating flotation separator
|
|
US7666674B2
(en)
*
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
|
WO2003040308A2
(en)
*
|
2001-07-27 |
2003-05-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo
|
|
AU2002318944A1
(en)
|
2001-08-01 |
2003-02-17 |
Coley Pharmaceutical Gmbh |
Methods and compositions relating to plasmacytoid dendritic cells
|
|
WO2003020884A2
(en)
*
|
2001-08-14 |
2003-03-13 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services |
Method for rapid generation of mature dendritic cells
|
|
IL160157A0
(en)
|
2001-08-17 |
2004-07-25 |
Coley Pharm Group Inc |
Combination motif immune stimulation oligonucleotides with improved activity
|
|
US20040259153A1
(en)
*
|
2001-08-22 |
2004-12-23 |
Yoshikazu Kurosawa |
Methods for selecting biding molecule
|
|
KR20040053136A
(ko)
|
2001-09-28 |
2004-06-23 |
펄듀 리서치 파운데이션 |
리간드-면역원 공액체를 이용한 치료 방법
|
|
WO2003031573A2
(en)
|
2001-10-05 |
2003-04-17 |
Coley Pharmaceutical Gmbh |
Toll-like receptor 3 signaling agonists and antagonists
|
|
JP2005519990A
(ja)
|
2001-10-12 |
2005-07-07 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
イミダゾキノリン化合物を用いて免疫応答を増強するための方法および産物
|
|
US7276489B2
(en)
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
AU2002366710A1
(en)
*
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
|
EP1474432A1
(en)
|
2002-02-04 |
2004-11-10 |
Biomira Inc. |
Immunostimulatory, covalently lipidated oligonucleotides
|
|
US8153141B2
(en)
|
2002-04-04 |
2012-04-10 |
Coley Pharmaceutical Gmbh |
Immunostimulatory G, U-containing oligoribonucleotides
|
|
CN101160399A
(zh)
|
2002-04-22 |
2008-04-09 |
拜奥尼茨生命科学公司 |
寡核苷酸组合物及其在调节免疫应答中的应用
|
|
AU2003229434A1
(en)
|
2002-05-10 |
2003-11-11 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
|
WO2003103586A2
(en)
|
2002-06-05 |
2003-12-18 |
Coley Pharmaceutical Group, Inc. |
Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory cpg nucleic acids
|
|
US20040053880A1
(en)
*
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7576066B2
(en)
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
AU2003255969A1
(en)
|
2002-07-17 |
2004-02-02 |
Coley Pharmaceutical Gmbh |
Use of cpg nucleic acids in prion-disease
|
|
NZ538628A
(en)
*
|
2002-08-12 |
2008-06-30 |
Dynavax Tech Corp |
Immunomodulatory compositions, methods of making, and methods of use thereof
|
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
|
US8043622B2
(en)
*
|
2002-10-08 |
2011-10-25 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
|
|
PT2241325E
(pt)
*
|
2002-10-29 |
2012-04-12 |
Coley Pharm Gmbh |
Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c
|
|
AU2003304107B2
(en)
*
|
2002-11-01 |
2008-05-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
|
|
EP1578954A4
(en)
|
2002-12-11 |
2010-08-11 |
Coley Pharm Group Inc |
5'-CPG NUCLEIC ACIDS AND USE METHOD
|
|
JP2006516099A
(ja)
|
2002-12-23 |
2006-06-22 |
ダイナバックス テクノロジーズ コーポレイション |
分枝状の免疫調節化合物及び該化合物の使用方法
|
|
AU2004206820B2
(en)
|
2003-01-16 |
2010-06-10 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
|
|
AU2004226605A1
(en)
*
|
2003-04-02 |
2004-10-14 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
|
WO2004094671A2
(en)
|
2003-04-22 |
2004-11-04 |
Coley Pharmaceutical Gmbh |
Methods and products for identification and assessment of tlr ligands
|
|
MXPA05013658A
(es)
*
|
2003-06-11 |
2006-03-02 |
Hybridon Inc |
Oligonucleotidos inmunomoduladores estabilizados.
|
|
BRPI0411514A
(pt)
|
2003-06-20 |
2006-08-01 |
Coley Pharm Gmbh |
antagonistas de receptor toll-like de molécula pequena
|
|
MXPA06000619A
(es)
|
2003-07-15 |
2006-04-11 |
Hybridon Inc |
Estimulacion sinergistica del sistema inmune usando oligonucleotidos inmunoestimuladores y/o compuestos inmunomeros en conjunto con citocinas y/o agentes quimioterapeuticos o terapia de radiacion.
|
|
EP1667694B1
(en)
*
|
2003-09-05 |
2010-04-28 |
Anadys Pharmaceuticals, Inc. |
Tlr7 ligands for the treatment of hepatitis c
|
|
CA2536139A1
(en)
|
2003-09-25 |
2005-04-07 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid-lipophilic conjugates
|
|
US20050215501A1
(en)
|
2003-10-24 |
2005-09-29 |
Coley Pharmaceutical Group, Inc. |
Methods and products for enhancing epitope spreading
|
|
GEP20094767B
(en)
*
|
2003-10-30 |
2009-09-10 |
Coley Pharm Group Inc |
C-class oligonucleotide analogs with enhanced immunostimulatory potency
|
|
US20050100983A1
(en)
|
2003-11-06 |
2005-05-12 |
Coley Pharmaceutical Gmbh |
Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling
|
|
CN101094594B
(zh)
|
2003-12-08 |
2012-08-15 |
海布里顿公司 |
通过基于小寡核苷酸的化合物调节免疫刺激性质
|
|
AU2005326144A1
(en)
*
|
2004-06-08 |
2006-08-03 |
Coley Pharmaceutical Gmbh |
Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist
|
|
US20060014713A1
(en)
|
2004-06-15 |
2006-01-19 |
Hybridon, Inc. |
Immunostimulatory oligonucleotide multimers
|
|
CA2574090A1
(en)
*
|
2004-07-18 |
2006-12-21 |
Coley Pharmaceutical Group, Ltd. |
Methods and compositions for inducing innate immune responses
|
|
MY159370A
(en)
*
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
|
WO2006056142A1
(en)
*
|
2004-11-29 |
2006-06-01 |
Changchun Huapu Biotechnology Co., Ltd. |
Cpg single-strand deoxynucleotides for use as adjuvant
|
|
CN1810970B
(zh)
*
|
2005-01-27 |
2011-05-18 |
长春华普生物技术有限公司 |
含CpG的单链脱氧核苷酸与其疫苗组合物及其应用
|
|
CN1847256B
(zh)
*
|
2005-04-13 |
2011-06-15 |
长春华普生物技术有限公司 |
含CpG单链脱氧寡核苷酸和利巴韦林联合应用产生的抗病毒作用
|
|
US7792535B2
(en)
*
|
2005-05-31 |
2010-09-07 |
Alcatel-Lucent Usa Inc. |
Enhanced mobile station paging in a wireless telecommunications network
|
|
JP2009500412A
(ja)
*
|
2005-07-07 |
2009-01-08 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
癌の処置のための、抗ｃｔｌａ−４抗体とｃｐｇモチーフ含有合成オリゴデオキシヌクレオチドとの組み合わせ治療
|
|
US7965675B2
(en)
*
|
2005-08-22 |
2011-06-21 |
Motorola Mobility, Inc. |
System and method for detecting an unlicensed mobile alliance (UMA) service in GSM wireless communication networks
|
|
CA2620582C
(en)
*
|
2005-08-31 |
2015-11-10 |
Dennis M. Klinman |
Methods of altering an immune response induced by cpg oligodeoxynucleotides
|
|
US8399423B2
(en)
*
|
2005-10-12 |
2013-03-19 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
|
PL1957647T3
(pl)
*
|
2005-11-25 |
2015-07-31 |
Zoetis Belgium S A |
Oligorybonukleotydy immunostymulujące
|
|
US20080045473A1
(en)
*
|
2006-02-15 |
2008-02-21 |
Coley Pharmaceutical Gmbh |
Compositions and methods for oligonucleotide formulations
|
|
EP2021008B1
(en)
*
|
2006-04-07 |
2015-12-02 |
Idera Pharmaceuticals, Inc. |
Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8
|
|
NZ575437A
(en)
*
|
2006-09-27 |
2012-02-24 |
Coley Pharm Gmbh |
Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
|
|
US8377898B2
(en)
*
|
2006-10-12 |
2013-02-19 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
|
MX2009005849A
(es)
*
|
2006-12-04 |
2009-08-12 |
Univ Illinois |
Composiciones y metodos para tratar cancer con adn rico en cpg y cupredoxinas.
|
|
KR20100053598A
(ko)
*
|
2007-08-01 |
2010-05-20 |
이데라 파마슈티칼즈, 인코포레이티드 |
Ｔｌｒ９의 신규한 합성 효능제
|
|
EP2190440A1
(en)
*
|
2007-08-13 |
2010-06-02 |
Pfizer Inc. |
Combination motif immune stimulatory oligonucleotides with improved activity
|
|
JP5753382B2
(ja)
*
|
2007-11-06 |
2015-07-22 |
アディウティーダ ファーマシューティカルズ ゲーエムベーハー |
修飾されたオリゴリン酸基を含有する免疫賦活オリゴリボヌクレオチドアナログ
|
|
KR20110081338A
(ko)
*
|
2008-11-04 |
2011-07-13 |
이데라 파마슈티칼즈, 인코포레이티드 |
안티센스 올리고누클레오티드에 의한 ｔｏｌｌ―유사 수용체 5 발현의 조절
|